Essential antifungal drugs are rare and expensive in Cameroon. However, there is an increasing resistance shown by Aspergillus spp to azoles in Cameroon. We aim for this project to determine antifungal susceptibility profiles (ASP) of Aspergillus spp isolated from symptomatic lung patients and from environmental samples, and to compare both profiles to determine any causal relationship.